On Friday, GeneDx Holdings Corp (NASDAQ: WGS) was -7.45% drop from the session before settling in for the closing price of $96.57. A 52-week range for WGS has been $2.85 – $98.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.08%. When this article was written, the company’s average yearly earnings per share was at 85.44%. With a float of $21.99 million, this company’s outstanding shares have now reached $27.43 million.
Let’s determine the extent of company efficiency that accounts for 1000 employees. In terms of profitability, gross margin is 54.23%, operating margin of -20.43%, and the pretax margin is -31.52%.
GeneDx Holdings Corp (WGS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GeneDx Holdings Corp stocks. The insider ownership of GeneDx Holdings Corp is 19.95%, while institutional ownership is 67.01%. The most recent insider transaction that took place on Jan 07 ’25, was worth 3,331,024. In this transaction CHIEF FINANCIAL OFFICER of this company sold 35,506 shares at a rate of $93.82, taking the stock ownership to the 2,472 shares. Before that another transaction happened on Jan 07 ’25, when Company’s Chief Executive Officer sold 51,420 for $94.48, making the entire transaction worth $4,858,119. This insider now owns 1,720 shares in total.
GeneDx Holdings Corp (WGS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.44% per share during the next fiscal year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
You can see what GeneDx Holdings Corp (WGS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.17, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.28 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Looking closely at GeneDx Holdings Corp (NASDAQ: WGS), its last 5-days average volume was 0.94 million, which is a jump from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 81.44%. Additionally, its Average True Range was 7.05.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 86.44%, which indicates a significant increase from 64.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.67% in the past 14 days, which was lower than the 91.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $77.94, while its 200-day Moving Average is $41.92. However, in the short run, GeneDx Holdings Corp’s stock first resistance to watch stands at $94.85. Second resistance stands at $100.31. The third major resistance level sits at $104.94. If the price goes on to break the first support level at $84.76, it is likely to go to the next support level at $80.13. Should the price break the second support level, the third support level stands at $74.67.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
There are 27,471K outstanding shares of the company, which has a market capitalization of 2.46 billion. As of now, sales total 202,570 K while income totals -175,770 K. Its latest quarter income was 76,870 K while its last quarter net income were -8,310 K.
